UNSPSC 51142517: Amantadine

This classification denotes an antiviral agent and cation channel blocker with the molecular formula C10H17N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BF4C9Z1J53, chemically known as 1-aminotricyclo(3.3.1.1(sup 3,7))decane but generally known as amantadine, which bears US NIH Compound Identifier 2130. Amantadine most often comes in base and hydrochloride\tforms and is often combined with ribavirin and interferon (alpha).

UNSPSC 51142517 Amantadine, a Commodity code, shows limited recent state and local procurement activity aligned with its nominal pharmaceutical scope. The single recent opportunity on record is a Seminole County, Florida IFB for naloxone and drug deactivation systems—products unrelated to amantadine—suggesting this code may be misapplied in state and local procurement systems or reflects inconsistent coding practices across jurisdictions. State and local buyers do not appear to be actively soliciting amantadine under this code at present based on available records.

Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, requesting 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The bid deadline was July 26, 2023, and vendors were required to submit electronically through the county's e-Procurement Portal, include all shipping and delivery costs in their pricing, maintain workers' compensation and commercial general liability insurance, and comply with E-Verify and drug-free workplace requirements. The contract was potentially funded through FEMA and carried a two-year initial term with a one-year renewal option and a three-month probationary termination clause.